News
Gland Pharma’s Pashamylaram facility has received GMP compliance certification from the Danish Medicines Agency for ...
Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback